Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProRelix Research is a global Clinical Research Organization (CRO) providing end-to-end clinical trial services to the pharmaceutical, biotechnology, and medical device industries. Headquartered in India with a presence in the United States, United Kingdom, and Europe, the company specializes in Phase I-IV clinical trials, regulatory affairs, and pharmacovigilance. Their service portfolio includes clinical data management, medical writing, and bioavailability/bioequivalence (BA/BE) studies. ProRelix Research focuses on delivering cost-effective and high-quality clinical development solutions across various therapeutic areas such as oncology and cardiology. The company is known for its ICH-GCP compliant processes and its commitment to accelerating the drug development lifecycle for global sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProRelix Research.